A randomized assessor-blinded triple arm pilot study to compare the efficacy of mometasone furoate 0.1% ointment versus crisaborole 2% ointment versus tofacitinib 2% ointment twice daily in patients with mild to moderate atopic dermatitis.

Name: A randomized assessor-blinded triple arm pilot study to compare the efficacy of mometasone furoate 0.1% ointment versus crisaborole 2% ointment versus tofacitinib 2% ointment twice daily in patients with mild to moderate atopic dermatitis.
Creator: Shreya K
Published: 2026-07-13T04:26:12.437Z
Keywords: Steroid Treatment, Atopic Dermatitis

K, Shreya; Bhari, Neetu

doi:10.17632/ch9pgb8k45.1

A randomized assessor-blinded triple arm pilot study to compare the efficacy of mometasone furoate 0.1% ointment versus crisaborole 2% ointment versus tofacitinib 2% ointment twice daily in patients with mild to moderate atopic dermatitis.

Published: 13 July 2026| Version 1 | DOI: 10.17632/ch9pgb8k45.1

Contributors:

,

Description

Topical tofacitinib 2% and crisaborole 2% demonstrated effective and well-tolerated steroid-sparing (mometasone furoate 0.1%) alternatives in mild-to-moderate atopic dermatitis.

Files

Institutions

All India Institute of Medical Sciences
Delhi, New Delhi

A randomized assessor-blinded triple arm pilot study to compare the efficacy of mometasone furoate 0.1% ointment versus crisaborole 2% ointment versus tofacitinib 2% ointment twice daily in patients with mild to moderate atopic dermatitis.

Description

Files

Institutions

Categories

Licence